Details for 2007795652

Up to date per 01.04.2026

Actions

Title / Product Name

NALTREXON-FORMULIERUNG MIT VERZÖGERTER FREISETZUNG

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2007795652

EP Publication Number

2061448

E-Number

1155186

Language

PCT Number

US07013030

Publication Date

27.05.2009 A

17.07.2019 B1

Registration Date

17.07.2019

AT Publication Date

15.08.2019

Application Date

31.05.2007

Registration Number

Priorities

05.06.2006

811251 P

29.08.2006

841114 P

IPC

A61K 31/135 20060101AFI20090129BHEP

Maximum Duration of Protection

31.05.2027

Owner

Nalpropion Pharmaceuticals, Inc.10 North Park Place, Suite 201 Morristown, NJ 07960US

Representative

No representatives present

Inventor

MCKINNEY, Anthony A.5457 Harvest Run Drive San Diego, California 92130US

TOLLEFSON, Gary D.9052 Diamond Pointe Drive Indianapolis, Indiana 46236US

SOLTERO, Richard5509 Solomon Seal Court Holly Springs, North Carolina 27540US

DUNZO, Thea Elise8 Barwinds Circle Durham, North Carolina 27713US